Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results
Artivion, Inc. (NYSE: AORT) announced the release date for its second quarter 2022 financial results, set for August 4, 2022, after market close. A teleconference will follow at 4:30 p.m. ET, hosted by Pat Mackin, CEO. Investors can access the live webcast through Artivion's website and a replay will be available shortly after the call. Artivion specializes in solutions for aortic diseases and markets its products in over 100 countries. For more details, visit www.artivion.com.
- None.
- None.
ATLANTA, July 21, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2022 financial results will be released on Thursday, August 4, 2022 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13730843.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
Contacts:
Artivion
D. Ashley Lee
Executive Vice President &
Chief Financial Officer
Phone: 770-419-3355
Gilmartin Group LLC
Brian Johnston / Lynn Lewis
Phone: 332-895-3222
investors@artivion.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-second-quarter-2022-financial-results-301590837.html
SOURCE Artivion, Inc.
FAQ
When will Artivion release its Q2 2022 financial results?
What time is the teleconference for Artivion's financial results?
How can I access the live webcast for Artivion's financial results?
Who will host the teleconference for Artivion’s Q2 financial results?
